5402222026-10-295402222026-10-292026-10-29iso4217:INRxbrli:pure540222LAURUS LABS LIMITEDLAURUSLABSNOTLISTEDINE947Q01028NewAcquisition (including agreement to acquire)true2026-10-2914:47:002026-10-29SI&C will take over the business of a partnership firm, namely, M/s SI & C Resins (the “Firm”), wherein all the founder directors and shareholders of SI&C, are partners in the Firm. The Firm was registered in the year 2022 and has turnover for the financial year 2024-25 was Rs. 3.55 Crore and for 2025-26 was Rs. 4.05 Crore.LAURUS LABS LIMITEDListed Entity (self)SI & C Resins Private Limited000falsefalsetrueSI&C specializes in the manufacturing and supply of high-quality polymer and silica-based products for the chemical, pharmaceutical, and biotechnology industries.As part of the overall Peptide strategy, the Company proposes to acquire a majority equity in SI&C and this will make Laurus offerings in Peptide manufacturing fully integrated. The proposed investment in SI&C will bring synergy to the business of the Company, while SI&C continue to develop new markets for its products. Indigenous resins, chromatography gels development, and large-scale manufacturing will help to capture fully integrated peptide manufacturing opportunities. Further, SI&C will set up a large-scale manufacturing plant by SI&C for peptide resins as solid phase peptide synthesis (SPPS) supports and chromatography gels. The acquisition will help us to build on the existing customer base and product pipeline to scale domestic resin manufacturing solutions for pharma and peptide manufacturing.NofalseThe Proposed Transaction is expected to be completed during the current financial year, subject to the completion of customary closing conditions and agreements which includes transfer of business of the Firm.Cash325000000The Proposed Transaction is contemplated by way of primary subscription to 10,833 equity shares of the SI&C at a consideration of Rs. 32.50 Crores, equivalent to 52% of the post-issue paid-up equity capital of SI&C.32500000000.52SI&C specializes in the manufacturing and supply of high-quality polymer and silica-based products for the chemical, pharmaceutical, and biotechnology industries. Wide range of products for various applications are as hereunder: Peptide and Peptidomimetic Synthesis; Absorption and separation of the heavy metals; Oxidation and reduction of the functional groups; Counter – Ion exchange of small molecules and APIs.2026-07-15SI&C has operations in India